Bart M. Remmerie
Janssen R&D
Beerse, VLG, Belgium
Beerse, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A phase 1 evaluation of inhaled oxytocin: Physiologically-based pharmacokinetic model informed dosing of a novel heat-stable oxytocin delivery system.
Journal: British journal of clinical pharmacology
Published: September 18, 2025
Establishing the Exposure-QT Relationship During Bedaquiline Treatment Using a Time-Varying Tuberculosis-Specific Correction Factor (QTcTBT).
Journal: CPT: pharmacometrics & systems pharmacology
Published: March 07, 2025
Closing the gaps in the access to quality-assured medicines for global health: The case for oxytocin for postpartum haemorrhage.
Journal: Expert review of clinical pharmacology
Published: January 08, 2025
Development and validation of a time-varying correction factor for QT interval assessment in drug-resistant tuberculosis patients.
Journal: International journal of antimicrobial agents
Published: May 17, 2024
Sub-MIC levels of bedaquiline and clofazimine can select Mycobacterium tuberculosis mutants with increased MIC.
Journal: Antimicrobial agents and chemotherapy
Published: March 12, 2024
Application of immunocapture and nanoflow LC-MS/MS to overcome the barriers to the quantitation of oxytocin in plasma of women in third stage labour.
Journal: British journal of clinical pharmacology
Published: October 11, 2023
Translational evaluation of novel selective orexin-1 receptor antagonist JNJ-61393215 in an experimental model for panic in rodents and humans.
Journal: Translational psychiatry
Published: April 30, 2020
Pharmacokinetics, Safety, and Antiviral Effects of Multiple Doses of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678, in Infants Hospitalized With RSV Infection: A Randomized Phase 1b Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 12, 2019
Integrating Duodenal Sampling in a Human Mass Balance Study to Quantify the Elimination Pathways of JNJ-53718678, a Respiratory Syncytial Virus Fusion Protein Inhibitor.
Journal: Advances in therapy
Published: May 27, 2019
Population Pharmacokinetics of Paliperidone Palmitate (Once-Monthly Formulation) in Japanese, Korean, and Taiwanese Patients With Schizophrenia.
Journal: Clinical pharmacology in drug development
Published: March 01, 2019
A Receiver Operating Characteristic Framework for Non-adherence Detection Using Drug Concentration Thresholds-Application to Simulated Risperidone Data in Schizophrenic Patients.
Journal: The AAPS journal
Published: September 19, 2018
Last Updated: 09/26/2026